Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions.
暂无分享,去创建一个
J Saldanha | J. Saldanha | M. Tsuchiya | T. Kishimoto | Y. Koishihara | Y. Ohsugi | K. Sato | T Kishimoto | K Sato | M Tsuchiya | Y Koishihara | Y Ohsugi | M M Bendig | M. Bendig | Yasuo Koishihara | Yoshiyuki Ohsugi | Jose Saldanha | Masayuki Tsuchiya | Koh Sato | Tadamitsu Kishimoto
[1] H. Imura,et al. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA. , 1992, Experimental hematology.
[2] R. Wheeler,et al. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response. , 1988, Journal of the National Cancer Institute.
[3] J. St,et al. Rapid PCR-cloning of full-length mouse immunoglobulin variable regions. , 1991 .
[4] A Tramontano,et al. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. , 1990, Journal of molecular biology.
[5] A. Lesk,et al. Conformations of immunoglobulin hypervariable regions , 1989, Nature.
[6] H. Waldmann,et al. Reshaping a therapeutic CD4 antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] P Davies,et al. Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences. , 1993, Journal of immunology.
[8] R. Sasaki,et al. Expression of the erythropoietin receptor on a human myeloma cell line. , 1990, Biochemical and biophysical research communications.
[9] T. Saito,et al. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. , 1990, Journal of biochemistry.
[10] G. Winter,et al. Antibody framework residues affecting the conformation of the hypervariable loops. , 1992, Journal of molecular biology.
[11] R. Schwartz,et al. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. , 1987, Journal of immunology.
[12] J. Schlom,et al. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. , 1991, Cancer research.
[13] Lutz Riechmann,et al. Reshaping human antibodies for therapy , 1988, Nature.
[14] A. Hasegawa,et al. Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo , 1992, European journal of immunology.
[15] S. Matsushita,et al. Construction of reshaped human antibodies with HIV-neutralizing activity. , 1991, Human antibodies and hybridomas.
[16] J Saldanha,et al. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. , 1991, Protein engineering.
[17] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[18] J. Saldanha,et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. , 1993, Cancer Research.
[19] N. Hilschmann,et al. Die Primärstruktur einer monoklonalen Immunglobulin-L-Kette der Subgruppe IV vom κ-Typ (Bence-Jones-Protein Len.) , 1975 .
[20] N. Hilschmann,et al. Die Primärstruktur einer kristallinen monoklonalen Immunglobulin-L-Kette vom κ-Typ, Subgruppe I (Bence-Jones-Protein Rei.), Isolierung und Charakterisierung der tryptischen Peptide; die vollständige Aminosäuresequenz des Proteins. Ein Beitrag zur Aufklärung der räumlichen Struktur der Antikörper, in , 1975 .
[21] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.
[22] S. Shimizu,et al. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines , 1989, The Journal of experimental medicine.
[23] J. Ghrayeb,et al. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. E. Ringwood,et al. Terrestrial origin of the Moon , 1986, Nature.
[25] T. Hirano,et al. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. , 1989, Journal of immunology.
[26] M. Matsuoka,et al. An established CD4+ T lymphoma cell line derived from a patient with so-called Lennert's lymphoma: possible roles of cytokines in histopathogenesis. , 1988, Blood.
[27] W. Grizzle,et al. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. , 1992, Human antibodies and hybridomas.
[28] C. Milstein,et al. Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.